AACC moves annual meeting from Anaheim to Atlanta
March 18, 2021 -- The American Association for Clinical Chemistry (AACC) is moving the location of its annual meeting from Anaheim, CA, to Atlanta and is shifting the date back one week in September. The AACC made the decision because of stringent COVID-19 lockdown requirements in California. Read More
FDA approves marketing of BioFire COVID-19 test
March 18, 2021 -- The U.S. Food and Drug Administration (FDA) announced it has granted marketing approval for the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs obtained from individuals suspected of COVID-19 and other respiratory tract infections. Read More
Roche signs $1.8B acquisition agreement with GenMark
March 16, 2021 -- Roche has inked a $1.8 billion acquisition agreement with GenMark Diagnostics. The deal is expected to close in the second quarter of this year. Read More
Thermo Fisher unveils assay panel to detect SARS-CoV-2 variants
March 10, 2021 -- Thermo Fisher Scientific has announced the launch of a customizable menu of 22 real-time polymerase chain reaction assays for the detection of SARS-CoV-2 mutations. Read More
Abbott gets EUA for COVID-19, flu, RSV assay
March 5, 2021 -- The U.S. Food and Drug Administration has granted Abbott an emergency use authorization (EUA) for its Alinity m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) in one test. Read More
PreludeDx touts study on DCIS results
March 5, 2021 -- Molecular diagnostics developer PreludeDx presented a study at the Miami Breast Cancer Conference 2021 annual meeting that showed ductal carcinoma in situ (DCIS) patients with higher scores on the firm's DCISionRT diagnostic test had an increased risk of breast cancer mortality. Read More
Qiagen launches automated sample processing for molecular testing
March 4, 2021 -- Qiagen has announced the launch of a fully automated sample processing platform for IVD applications in molecular diagnostic laboratories. Read More
New AI-powered imaging tool estimates hemoglobin levels
March 2, 2021 -- A novel chip-based microfluidic diagnostic platform, featuring a microfluidic chip and an artificial intelligence (AI)-powered automated microscope, can estimate hemoglobin levels in whole blood samples less expensively than hematology analyzers, according to research published February 23 in AIP Advances. Read More
Hologic acquires Diagenode for $159 million
March 1, 2021 -- Hologic has purchased European molecular diagnostic assay and epigenetic product developer Diagenode for $159 million in a deal that will expand Hologic's molecular diagnostics business internationally. Read More
Market for COVID-19 diagnostics to hit $38B by year end
February 26, 2021 -- As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently. Bruce Carlson of Kalorama Information discusses how COVID-19 testing has quickly risen to rival other more established segments of the IVD market. Read More